Automated measurement of serum ferroxidase activity

Clinical Chemistry

Volumn 44, Issue 11, 1998, Pages 2313-2319

  Erel, Ozcan ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; FERRIC ION; OXIDOREDUCTASE; PHENYLENEDIAMINE;

ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HUMAN;

EID: 0031760199     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.11.2313     Document Type: Article

References (16)

1. Young SN, Curzon G. A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem J 1972;129: 273-83.
2. Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970;16:903-10.
3. Winkles J, Jones AF, Winyard P, Blake DR, Lunec J. An automated method for the kinetic measurement of ferroxidase activity. Ann Clin Biochem 1988;25:250-4.
4. Takayanagi M, Yashiro T. Determination of human serum ceruloplasmin by ion chromatography based on its ferroxidase activity. J Chromatogr 1986;374:378-82.
5. Artiss JD, Vinogradov S, Zak B. Spectrophotometric study of several sensitive reagents for serum iron. Clin Biochem 1981;14: 311-5.
6. David BM. Trace elements. In: Burtis AC, Ashwood ER, eds. Tietz textbook of clinical chemistry 2nd ed. Philadelphia: WB Saunders, 1994:1338-9.
7. Holmberg CG, Laurell CB. Investigations in serum copper. II. Isolation of the copper containing protein and a description of some of its properties. Acta Chem Scand 1948;2:550-6.
8. Ehrenwald E, Chisolm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Investig 1994; 93:1493-501.
9. Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65:238-309.
10. Swain JA, Darley-Usmar V, Gutteridge JM. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett 1994;342:49-52.
11. Schosinsky H, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974;20:1556-63.
12. Olivares M, Uauy R. Copper as an essential nutrient. Am J Clin Nutr 1996;63:791-6.
13. Pacht ER, Davis WB. Decreased ceruloplasmin ferroxidase activity in cigarette smokers. J Lab Clin Med 1988;111:661-8.
14. Fleming RE, Whitman IP, Gitlin JD. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am J Physiol 1991;260:L68-74.
15. Saenko EL, Skorobogat'ko OV, Yaropolov AI. Immunoenzyme determination of total serum ceruloplasmin. Application to Wilson disease. Biochem Int 1991;23:819-24.
16. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997;27:358-62.